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Letters to the Editor
Keratin 19 mRNA is detectable by RT-PCR in lymph
nodes of patients without breast cancer
Sir
We were interested to read the paper on the use of cytokeratin 19
(K19) mRNA by reverse transcription polymerse chain reaction
(RT- PCR) combined with Southern blotting for the detection of
lymph node micrometastasis in breast cancer patients by
Schoenfeld et al (1996). The authors have reported that, among 75
histologically node-negative breast cancer patients, 23 (30.6%)
demonstrate K19 mRNA in their lymph nodes whereas none of 28
control lymph nodes without epithelial malignancy show K19
expression.
This report and another by Traweek et al (1993) are in sharp
contrast with our data in that K19 mRNA is readily detected by
RT-PCR in 31 of 40 (77.5%) lymph nodes from five of eight
patients with benign bowel diseases, none ofwhom had any signs
of an epithelial malignancy. We also found that two of these same
eight had K19-positive bone marrow aspirates. Our methods
involve extremely careful dissection of lymph nodes before
cutting any epithelial tissue to avoid epithelial cell contamination
from surgical gloves or dissection equipment. RNA extractions
were performed, including blank samples, so that reagent contam-
ination could not account for positive results. Our PCR strategy
allows discrimination of K19 cDNA-derived PCR products from
K19 genomic DNA- or K19 pseudogene-derived PCR products,
methodologies of which have recently been published by Gunn et
al (1996). Furthermore, we showed that the 31 lymph nodes that
expressed K19 mRNA did not express keratin 20, a gene
expressed highly by the epithelial cells ofthe gastrointestinal tract
only) ruling out epithelial cell contamination as the source of K19
mRNA in these lymph nodes. Among 35 breast cancer patients so
far studied, 17 were histologically node negative whereas 18 were
histologically node positive. Ninety-five of 143 lymph nodes
(66.4%) from the former group and 128 of 166 lymph nodes
(77.1%) from the latter group were found to be K19 positive by
RT-PCR. From these findings we have concluded that a low level
of K19 mRNA is expressed in most lymph nodes, and that these
data concur with previous reports by Krisman et al (1995), Adams
et al (1995) and Burchill et al (1995).
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Keratin 19 mRNA is detectable by RT-PCR in lymph
nodes of patients without breast cancer - reply
Sir
We agree that K19 mRNA is detectable in normal lymph nodes
(from patients without any epithelial malignancy) by reverse tran-
scription polymerase chain reaction (RT-PCR) after many cycles
of amplification. In our paper (Schoenfeld et al, 1994), we
described the methodology and demonstrated a 'cut-off' of 40
cycles of amplification beneath which all normal lymph nodes
remained negative for K19 mRNA; those above this level may be
taken to indicate lymph node metastases. In our studies, this 'cut-
off' occurred after40cycles ofRT-PCR and Southern hybridization.
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